Recordati announced strong 2026 first half results
Revenue rose 6.6%, EBITDA 8.8%, and adjusted net income 6.7%, plus a new licensing deal for a neurological condition.
See the latest news and media coverage for Recordati. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global pharmaceutical company
recordati.comLast updated
In short: Recordati celebrated its 100th anniversary as Respighi BidCo, backed by CVC and GBL, launched a €12.4 billion bid to take the firm private.
Revenue rose 6.6%, EBITDA 8.8%, and adjusted net income 6.7%, plus a new licensing deal for a neurological condition.
The report provides financial results and operational highlights for the six months ended June 30, 2026
It follows Article 36 of the Italian Issuers' Regulation regarding mandatory offers.
The statement relates to the voluntary takeover bid for all Recordati shares launched by Respighi BidCo.
(Il Sole 24 Ore Radiocor) - Milan, July 29 - 'The operation proposed by Cvc and Gbl is subject to the ongoing offer process. The...
Financial targets for fiscal year 2026 confirmed (Il Sole 24 Ore Radiocor) - Milan, July 28 - Recordati recorded in the first half...
Real-time financial news from MF Market Driver. Follow market trends, stock exchange listings and the main national economic news and...
European healthcare M&A volumes rose 56% to EUR 40bn in 1H26, driven by strategic buyers.
Track Recordati and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Recordati and other trending companies.